Incretin therapy may benefit patients with diabetes and STEMI

Access to the full content of this site is available only to registered healthcare professionals. Register to read more

Takeaway

  • Incretin therapy may be optimal for patients with type 2 diabetes (T2D) and ST elevation myocardial infarction-multivessel nonobstructive coronary stenosis (STEMI-Mv-NOCS).

Why this matters

  • Few data guide management of patients with T2D with STEMI-Mv-NOCS.

Study desig...